Jiangsu Hengrui Medicine | Sustainability & Chart

CNE0000014W7

Basic information on Jiangsu Hengrui Medicine

Location: China

Industry: Manufacturing

Website

Impact Score

Description Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine is a Chinese pharmaceutical company engaged in the research, development, manufacture, and sale of prescription drugs. Its portfolio includes oncology, anesthetics, imaging agents, and other therapeutic products.

Jiangsu Hengrui Medicine Sustainability Performance

Climate

10%

Renewable Energy

No data available for Jiangsu Hengrui Medicine. Target value per method: min. 100%

Greenhouse Gas Emissions

Jiangsu Hengrui Medicine emits 3,3 times its CO₂ budget of 100,131 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget

Supply Chain

Taking into account the entire supply chain, Jiangsu Hengrui Medicine emits 10,8 times its CO₂ budget of 100,131 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget

Recycling and Recovery of Waste

No data available for Jiangsu Hengrui Medicine. Target value per method: min. 75%

Society

51%

Union Formation and Collective Bargaining Power

No data available for Jiangsu Hengrui Medicine. Target value per method: min. 80%

CEO Pay Ratio

CEO Sun Piaoyang earns 827 times the average salary of employees. Target value per method: max. 20 times

Employee Turnover Rate

Jiangsu Hengrui Medicine has an employee turnover rate of 8,3%. Target value per method: max. 10%

Harassment and Discrimination at the Workplace

Jiangsu Hengrui Medicine meets 4 quality criteria for handling harassment and discrimination at the workplace. Target value per method: 4 quality criteria

Gender

57%

Women on Board

Jiangsu Hengrui Medicine has 22,2% women across its top leadership and supervisory bodies. Target value per method: min. 40%

Gender Pay Gap

No data available for Jiangsu Hengrui Medicine. Target value per method: max. 3%

Women in Management

Jiangsu Hengrui Medicine employs 35% female managers. Target value per method: min. 40%

Glass Ceiling

The proportion of women in senior management at Jiangsu Hengrui Medicine is 76,1% of the proportion of women in the overall workforce. Target value per method: min. 90%

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

Renewable Energy

Greenhouse Gas Emissions

Supply Chain

Waste Recycling

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

Compare Jiangsu Hengrui Medicine with ...

Jiangsu Hengrui Medicine

?

Impact Score

Climate

Society

Gender

10%

51%

57%

Jiangsu Hengrui Medicine

?

Impact Score

Climate

Society

Gender

Sources of sustainability performance

Metric	Value	Unit	Year	PDF Name	PDF Page
CEO Pay Ratio
Number of employees	20 602	people	2025	2026032600021.pdf	43
Total wages paid	41 156	RMB'000	2025	2026032600021.pdf	145
CEO salary	1 653	RMB’000	2025	2026032600021.pdf	3
CEO name	Sun Piaoyang		2025	2026032600021.pdf	3
Employee Turnover Rate
Employee turnover	8,31	%	2025	f.pdf	47
Glass Ceiling
Women in management	35	%	2025	f.pdf	46
Women in workforce	46	%	2025	f.pdf	46
Greenhouse Gas Emissions
Scope 2 emissions, location based	270 564,48	Tonnes of CO₂ equivalent	2025	f.pdf	30
Number of employees	20 602	people	2025	2026032600021.pdf	43
Scope 1 emissions	54 874,45	Tonnes of CO₂ equivalent	2025	f.pdf	30
Harassment and Discrimination at the Workplace
Anti-discrimination policy	Yes		2025	2026032600021.pdf	59
Confidentiality mechanisms	Yes		2025	f.pdf	17
Incident notification mechanism	Yes		2025	f.pdf	14
Retaliation safeguards	Yes		2025	f.pdf	52
Supply Chain
Scope 1 emissions	54 874,45	Tonnes of CO₂ equivalent	2025	f.pdf	30
Number of employees	20 602	people	2025	2026032600021.pdf	43
Scope 2 emissions, location based	270 564,48	Tonnes of CO₂ equivalent	2025	f.pdf	30
Scope 3 emissions	756 662,33	Tonnes of CO₂ equivalent	2025	f.pdf	30
Women on Board
Executive board size	7	people	2025	f.pdf	46
Supervisory board size	11	people	2025	2026032600021.pdf	47
Women on executive board	2	people	2025	f.pdf	46
Women on supervisory board	2	female	2025	2026032600021.pdf	58
Women in Management
Women in management	35	%	2025	f.pdf	46

Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable companies

Home Find Companies & ETFs Learn to invest Academy Glossary Our Method

Imprint Privacy Policy GTC FAQContact Us

© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support! Reference data includes information from ESMA FIRDS that has been transformed and enriched by money:care. The use of this reference data does not constitute endorsement of or support for money:care or its products by ESMA. Fund information is based in part on publications by the respective providers and has been processed by money:care. Logos provided by Logo.dev